DGX vs STAA · P/E 22, rev $5.94B vs rev $187.1M
Quest Diagnostics Incorporated (DGX) versus STAAR Surgical Company (STAA) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
STAAR Surgical Company (STAA) is a medical instruments & supplies company listed on NASDAQ.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported STAA revenue for 2026-07-03 was $187.1M. Net income was $13.3M. STAA currently screens at market cap $1.45B.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. STAA currently screens at market cap $1.45B.
Not investment advice. Open the DGX and STAA stock pages for the full models.
Not investment advice.